Search Results - "Garinei, R"
-
1
Hyperthermic Isolated Perfusion with Tumor Necrosis Factor-alpha and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue Sarcoma: The Experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)
Published in In vivo (Athens) (01-03-2009)“…Background: Tumor necrosis factor-alpha (TNFα)-based hyperthermic isolated limb perfusion (HILP) is routinely carried out at most oncological institutions in…”
Get full text
Journal Article -
2
Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status
Published in Journal of experimental & clinical cancer research (01-03-2007)“…This study aims to correlate the most important prognostic factors of primary melanoma with sentinel node (SN) positive for metastases. We have enrolled 84…”
Get more information
Journal Article -
3
Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha
Published in Journal of experimental & clinical cancer research (01-06-2004)“…The aim of this study was to evaluate the systemic and haemodynamic postoperative effects of ILP with medium-low dose of TNF alpha in patients diagnosed with…”
Get more information
Journal Article -
4
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma
Published in Journal of experimental & clinical cancer research (01-12-2003)“…Hyperthermic antiblastic perfusion/HAP) has been proven to be an effective neoadjuvant treatment in the treatment of advanced soft tissue limb sarcoma. As a…”
Get more information
Journal Article -
5
Liposomal Doxorubicin in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma
Published in Journal of chemotherapy (Florence) (01-11-2004)“…Liposome-containing doxorubicin has been employed in the treatment of advanced soft tissue limb sarcoma during hyperthermic perfusion. A phase I-II study was…”
Get full text
Journal Article -
6
Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma
Published in Annals of oncology (01-04-1992)“…Eighty patients with locally advanced, high grade soft tissue sarcoma of the extremities were studied prospectively in order to determine the efficacy of…”
Get more information
Journal Article -
7
Appendicitis with pseudo-neoplastic manifestations
Published in Chirurgia italiana (01-01-1950)Get more information
Journal Article -
8
The treatment of limb soft tissue sarcoma with TNF-alfa and pegylated liposomal doxorubicin (PLD): Phase I-II study
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
9
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion
Published in In vivo (Athens) (01-03-2009)“…In isolated limb perfusion (ILP) with tumor necrosis factor-alpha (TNFalpha) and interferon (IFN)-gamma, pioneered by Lienard and Lejenne in 1988, TNFalpha was…”
Get full text
Journal Article -
10
Prognostic Factors Influencing Tumor Response, Locoregional Control and Survival, in Melanoma Patients with Multiple Limb In-transit Metastases Treated with TNFα-based Isolated Limb Perfusion
Published in In vivo (Athens) (01-03-2009)“…Background: In isolated limb perfusion (ILP) with tumor necrosis factor-alpha (TNFα) and interferon (IFN)-γ, pioneered by Lienard and Lejenne in 1988, TNFα…”
Get full text
Journal Article -
11
Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase
Published in Tumori (01-07-2003)“…Primary limb melanoma may recur in terms of satellitosis, in transit metastases and/or regional node involvement. Hyperthermic antiblastic perfusion (HAP)…”
Get full text
Journal Article -
12
TNFa-based isolated hyperthermic limb perfusion (HILP) in the treatment of limb recurrent melanoma: update 16 years after its first clinical application
Published in Journal of chemotherapy (Florence) (01-11-2004)“…Hyperthermic Limb Perfusion (HILP) with Tumor Necrosis Factor alpha (TNFalpha) and interferon gamma (IFNgamma) was pioneered by Liénard and Lejeune in 1988…”
Get full text
Journal Article -
13
TNFα-Based Isolated Hyperthermic Limb Perfusion (HILP) in the Treatment of Limb Recurrent Melanoma: Update 16 Years after Its First Clinical Application
Published in Journal of chemotherapy (Florence) (01-11-2004)“…Hyperthermic Limb Perfusion (HILP) with Tumor Necrosis Factor alpha (TNFα) and interferon gamma (IFNγ) was pioneered by Liénard and Lejeune in 1988. TNFα was…”
Get full text
Journal Article -
14
Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study
Published in Journal of experimental & clinical cancer research (01-12-2003)“…Hyperthermic antiblastic perfusion (HAP) has been proven to be an effective treatment of loco-regional spreading limb melanoma. The mean complete response (CR)…”
Get more information
Journal Article -
15
Hyperthermic antiblastic perfusion in the treatment of locoregional spreading limb melanoma
Published in Journal of experimental & clinical cancer research (01-12-2003)“…On the basis of personal experience and a review of the literature, the authors have evaluated the results obtained with hyperthermic antiblastic perfusion…”
Get more information
Journal Article -
16
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study
Published in Journal of immunotherapy (1997) (01-09-1999)“…To improve the therapeutic effectiveness of hyperthermic antiblastic perfusion (HAP), the association of recombinant tumor necrosis factor alpha (rTNF alpha),…”
Get more information
Journal Article -
17
Effects of isolated limb perfusion with tumor necrosis factor-α on circulating levels of proinflammatory cytokines
Published in Journal of immunotherapy (1997) (01-07-2001)“…Hyperthermic isolated limb perfusion (ILP) with tumor necrosis factor-a (TNFalpha) and cytotoxic drugs is currently used for treatment of melanoma and sarcoma…”
Get full text
Journal Article -
18
-
19
The application of hyperthermia in regional chemotherapy
Published in Seminars in surgical oncology (01-04-1998)“…To evaluate the role of hyperthermia combined with chemotherapy in the loco‐regional treatment of tumors, a retrospective analysis was done with 228 limb…”
Get full text
Journal Article -
20
Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma
Published in World journal of surgery (01-05-1995)“…Thirty‐two patients with recurrent (skin) or metastatic (skin, mode, or both) melanoma have been treated with a hyperthermiacisplatin regimen. The hyperthermic…”
Get full text
Journal Article